Long-term effects of methylphenidate transdermal delivery system treatment of ADHD on growth

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 46, Issue 9, 2007, Pages 1138-1147

  Faraone, Stephen V ^a,c   Giefer, Eldred E ^b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b Lineberry Associates   (United States)

^c NONE   (United States)

Author keywords

Attention deficit hyperactivity disorder; Growth; Methylphenidate; Stimulants; Transdermal

Indexed keywords

METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GROWTH CURVE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BODY MASS INDEX; CHILD; FEMALE; GROWTH; HUMANS; MALE; METHYLPHENIDATE; TIME FACTORS;

EID: 34548071102     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/chi.0b013e31806ad1d7     Document Type: Article

References (28)

1. Biederman J, Lopez FA, Boellner SW, Chandler MC (2002), A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 in children with attention deficit hyperactivity disorder. Pediatrics 110:258-266
2. Charach A, Figueroa M, Chen S, Ickowicz A, Schachar R (2006), Stimulant treatment over five years: effects on growth. J Am Acad Child Adolesc Psychiatry 45:415-421
3. Faraone SV, Biederman J, Monuteaux M, Spencer T (2005), Long-term effects of extended-release mixed amphetamine salts treatment of attention-deficit/ hyperactivity disorder on growth. J Child Adolesc Psychopharmacol 15:191-202
4. Gittelman R, Landa B, Mattes J, Klein D (1988), Methylphenidate and growth in hyperactive children: a controlled withdrawal study. Arch Gen Psychiatry 45:1127-1130
5. Greenhill LL, Findling RL, Swanson JM (2002a), A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 109:E39
6. Greenhill LL, Pelham W, Lopez FA, et al. (2002b), Once-daily transdermal methylphenidate improves teacher, parent, and CGI-I ratings. Presented at the 49th Annual Meeting of the American Association of Child and Adolescent Psychiatry, San Francisco, October 22-27
7. Gross M (1976), Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine. Pediatrics 58:423-431
8. Klein R, Mannuzza S (1988), Hyperactive boys almost grown up: III. Methylphenidate effects on ultimate height. Arch Gen Psychiatry 45:1131-1134
9. Kuczmarski RJ, Ogden CL, Guo L, et al. (2002), 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11:1-190
10. Lisska MC, Rivkees SA (2003), Daily methylphenidate use slows the growth of children: a community based study. J Pediatr Endocrinol Metab 16:711-718
11. Loney J, Whaley KMA, Ponto LB, Adney K (1981), Predictors of adolescent height and weight in hyperkinetic boys treated with methylphenidate [proceedings]. Psychopharmacol Bull 17:132-134
12. Mattes JA, Gittelman R (1983), Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry 40:317-321
13. McGough JJ, Pataki CS, Suddath R (2005), Dexmethylphenidate extendedrelease capsules for attention deficit hyperactivity disorder. Expert Rev Neurother 5:437-441
14. McGough JJ, Wigal SB, Abikoff H, Turnbow JM, Posner K, Moon E (2006), A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD. J Atten Disord 9:476-485
15. MTA Cooperative Group (2004), National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 113:762-769
16. Pelham WE, Manos MJ, Ezzell CE, et al. (2005), A dose-ranging study of a methylphenidate transdermal system in children with ADHD. J Am Acad Child Adolesc Psychiatry 44:522-529
17. Poulton A (2005), Growth on stimulant medication; clarifying the confusion: a review. Arch Dis Child 90:801-806
18. Poulton A, Cowell CT (2003), Slowing of growth in height and weight on stimulants: a characteristic pattern. J Paediatr Child Health 39:180-185
19. Safer D, Allen R (1973), Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. J Pediatr 51:660-667
20. Safer D, Allen R, Barr E (1975), Growth rebound after termination of stimulant drugs. Pediatrics 86:113-116
21. Satterfield JH, Cantwell DP, Schell A, Blaschke T (1979), Growth of hyperactive children treated with methylphenidate. Arch Gen Psychiatry 36:212-217
22. Spencer T, Faraone SV, Biederman J, Lerner M, Cooper K, Zimmerman B (2006), Does prolonged stimulant therapy suppress growth in children with ADHD? analysis of data from 21 months of therapy with once-daily OROS® MPH. J Am Acad Child Adolesc Psychiatry 45:527-537
23. Swanson J, Greenhill L, Wigal T, et al. (2006), Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry 45:1304-1313
24. Swanson JM, Elliott GR, Greenhill LL et al., MTA Collaborative Group (2007), Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry 46:1014-1025
25. Swanson JM, Ruff DD, Feldman PD, Furr AJ, Allen AJ (2005), Characterization of growth in children with ADHD. Presented at the Meeting of the American Academy of Child and Adolescent Psychiatry and Canadian Academy of Child and Adolescent Psychiatry, Toronto, October 18-23
26. Wigal S, McGough JJ, Abikoff H, Turnbow JM, Posner K, Moon E (2005), Behavioral effects of methylphenidate transdermal system in children with ADHD. Presented at the Meeting of the American Academy of Child and Adolescent Psychiatry and Canadian Academy of Child and Adolescent Psychiatry, Toronto, October 18-23
27. Wigal S, Swanson JM, Feifel D, et al. (2004), A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threomethylphenidate hydrochloride in children with attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 43: 1406-1414
28. Wolraich M, Greenhill LL, Pelham W, et al. (2001), Randomized controlled trial of OROS methylphenidate qd in children with attention deficit/ hyperactivity disorder. Pediatrics 108:883-892